Plasma N-terminal Prosomatostatin and Risk of Incident Cardiovascular Disease and All-Cause Mortality in a Prospective Observational Cohort: the PREVEND Study. (2017)
Attributed to:
Aetiology of type 2 diabetes and related metabolic disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1373/clinchem.2016.259275
PubMed Identifier: 28062624
Publication URI: http://europepmc.org/abstract/MED/28062624
Type: Journal Article/Review
Volume: 63
Parent Publication: Clinical chemistry
Issue: 1
ISSN: 0009-9147